A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer
about
Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancerIdentification of Biomarkers for Breast Cancer Using Databases.Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways.STK33 overexpression in hypopharyngeal squamous cell carcinoma: possible role in tumorigenesisTrianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidenceSuppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.COX-2 in cancer: Gordian knot or Achilles heel?Live imaging of tumor initiation in zebrafish larvae reveals a trophic role for leukocyte-derived PGE₂.Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.Modulation of the prostaglandin-endoperoxide synthase 2 gene expression by variant haplotypes: influence of the 3'-untranslated region.Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.Retrospective evaluation of COX-2 expression, histological and clinical factors as prognostic indicators in dogs with renal cell carcinomas undergoing nephrectomy.The pharmacologic inhibition of the xc- antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis.Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes.
P2860
Q26828414-3CF393F7-3780-46DF-B912-16D5E2DE20AAQ30239810-73323042-C994-42EF-94DF-1C3BEC78F6A0Q33749203-912BD218-DF50-4068-A038-675432BDFACCQ35008698-5CD8A21F-1000-4015-BC06-52FC1C029918Q35138880-40FD4A9A-3F0B-4A7B-A9BE-DE3BE0376070Q36267669-E1809447-B6DF-423B-8626-65D321272AB5Q37466405-64DDDF7A-92EB-4250-A290-A64C2CFF4951Q37709099-B0CC02F5-E30C-4950-833C-F0AA63CA8C02Q38098398-84ED1777-1228-402C-A848-1D1AAD3E915AQ42239372-D500A431-9212-44A7-9DAE-27AF05B7A78EQ44827493-C99CF8C8-0554-42EA-A71A-C88A2BAA1069Q47099229-15C7D4D0-27CF-4533-8140-7603521B0043Q47582021-E1945F3A-A5A9-4611-86DA-F6ADD3BEE260Q51830405-06215BBA-7CAD-4888-83B1-7F141FA502DFQ53262015-B18AD020-F451-43A1-ABFE-01B06E133DFCQ53389613-08357B46-4747-4928-939B-CB6A28F2C57D
P2860
A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A systematic review to establi ...... ast and invasive breast cancer
@ast
A systematic review to establi ...... ast and invasive breast cancer
@en
type
label
A systematic review to establi ...... ast and invasive breast cancer
@ast
A systematic review to establi ...... ast and invasive breast cancer
@en
prefLabel
A systematic review to establi ...... ast and invasive breast cancer
@ast
A systematic review to establi ...... ast and invasive breast cancer
@en
P2093
P2860
P921
P356
P1476
A systematic review to establi ...... ast and invasive breast cancer
@en
P2093
C M Hughes
J A Glover
L J Murray
M M Cantwell
P2860
P2888
P356
10.1038/BJC.2011.204
P407
P577
2011-06-07T00:00:00Z
2011-06-28T00:00:00Z